| Literature DB >> 17303800 |
Noa Weinberg1, Limor Ouziel-Yahalom, Sarah Knoller, Shimon Efrat, Yuval Dor.
Abstract
Understanding and manipulating pancreatic beta-cell proliferation is a major challenge for pancreas biology and diabetes therapy. Recent studies have raised the possibility that human beta-cells can undergo dedifferentiation and give rise to highly proliferative mesenchymal cells, which retain the potential to redifferentiate into beta-cells. To directly test whether cultured beta-cells dedifferentiate, we applied genetic lineage tracing in mice. Differentiated beta-cells were heritably labeled using the Cre-lox system, and their fate in culture was followed. We provide evidence that mouse beta-cells can undergo dedifferentiation in vitro into an insulin-, pdx1-, and glut2-negative state. However, dedifferentiated beta-cells only rarely proliferate under standard culture conditions and are eventually eliminated from cultures. Thus, the predominant mesenchymal cells seen in cultures of mouse islets are not of a beta-cell origin.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17303800 DOI: 10.2337/db06-1654
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461